New approach to heart rate variability analysis based on cardiophysiological biomarkers
Journal Title: Moldovan Medical Journal - Year 2018, Vol 61, Issue 3
Abstract
Background: The heart rate variability (HRV) analysis is a well-known method demonstrating its value over the years in different medical fields. However, it still has its known limitations. Material and methods: The new approach to HRV analysis is based on a complementary HRV standard analysis with new cardiophysiological biomarkers. The biomarkers are assessed on cardiorhythmograms obtained by a 5-minute ECG recording using a specialized hardware (Polyspectrum-HRV-device, Neurosoft). Results: A possible applicative value of the biomarkers is shown on examples of how a prognosis for recurrence of atrial fibrillation (AFib) could be made. When in a rest-state cardiorhythmogram are observed LF drops and are followed by a pathological counterregulation, prognostically, recurrence of atrial fibrillation is expected. When in a cardiorhythmogram LF drops are observed and are followed by a physiological counterregulation, prognostically, sinus rhythm is expected. Physiological background of the biomarkers: increased central modulation of the heart in rest state of a patient, a sympathetic overflow of the heart in calm state and insufficiency of compensatory parasymphatetic counteractivation. Limitations of the paper: this is a methodological paper without description of patients. This paper will be followed by a clinical paper in which we are going to describe the validation of these cardiophysiological biomarkers on patients with AFib. Conclusions: Complementary to the standard HRV analysis, cardiophysiological biomarkers should be assessed: LF drops and HF counterregulation could be used for prognosis construction in cardiology.
Authors and Affiliations
Ludmila Sidorenko, Ivan Diaz-Ramirez, Victor Vovc, Gert Baumann
Keywords
Related Articles
- EP ID EP480543
- DOI 10.5281/zenodo.1465926
- Views 194
- Downloads 0
The role of scientific research in the field of medicines and the development of the pharmaceutical industry
Background: Approximately 91% of drugs are imported, some of which are quite expensive and unaffordable for the majority of the population. The process of drug development, i. e. the pathway from synthesis of active subs...
Usage of cardiotonic drugs at the intensive care units
Background: Circulation insufficiency is one of the most common dysfunctions in the patients admitted to the intensive care units (ICU) [1]. These patients need an intravenous (IV) vasoactive drug administration to optim...
Interests in knowledge and assistance of epilepsy
Background: Many problems with differential treatment of epilepsy require further clarification. As far as we are concerned, we have developed therapeutic recommendations which, in our opinion, demonstrated to be effecti...
Inoffensivity of imupurin in pregnancy
Background: Determination of imupurin inoffensivity on embryogenesis, organogenesis and teratogenesis in rats. Material and methods: The study of immupurin’s safety during pregnancy was performed on 60 rats, divided into...
Coronary revascularization in patients with ischemic left ventricular dysfunction
Background: Coronary artery disease (CAD) dominates in the contemporary world among the causes of left ventricular dysfunction (LVD). Prognosis of survival and the course of heart failure (HF) are worse in patients with...